Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

Cited by (785)

Items 301–400 of 785

1. Influence of Androgens on Circulating Adiponectin in Male and Female Rodents
   Joshua F. Yarrow, Luke A. Beggs, Christine F. Conover, Sean C. McCoy, Darren T. Beck, Stephen E. Borst · 2012 · PLoS ONE
2. Testosterone Deficiency and Risk Factors in the Metabolic Syndrome: Implications for Erectile Dysfunction
   André T. Guay, Abdulmaged M. Traish · 2011 · Urologic Clinics of North America
3. Biochemical endocrinology of the hypogonadal male
   Paul E. Belchetz, Julian H. Barth, Jean‐Marc Kaufman · 2010 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
4. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
   Anthonia Okeoghene Ogbera, Sonny Chinenye, Fasanmade A. Olufemi, Wale Ajala · 2011 · PubMed
5. Effects of ginseng on peripheral blood mitochondrial DNA copy number and hormones in men with metabolic syndrome: A randomized clinical and pilot study
   Dong‐Hyuk Jung, Yong‐Jae Lee, Chun-Bae Kim, Jang‐Young Kim, Seung-Hun Shin, Jong-Ku Park · 2015 · Complementary Therapies in Medicine
6. Metabolic syndrome and hypogonadism – two peas in a pod
   Fahim Ebrahimi, Mirjam Christ‐Crain · 2016 · Swiss Medical Weekly
7. Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
   Abdulmaged M. Traish, Vanessa Johansen · 2018 · The World Journal of Men s Health
8. Effect of Testosterone Administration on Liver Fat in Older Men With Mobility Limitation: Results From a Randomized Controlled Trial
   Grace Tzu-Wei Huang, Shalender Bhasin, Elizabeth Tang, Adam Aakil, Stephan William Anderson, Hernan J. Jara, Maithili N. Davda, Thomas G. Travison, Shehzad Sultan Basaria · 2013 · The Journals of Gerontology Series A
9. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
   Kathleen Hwang, Martin M. Miner · 2014 · Asian Journal of Andrology
10. Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study
    Aksam A Yassin, Mustafa Mohamed Alwani, Raidh Talib Alzubaidi, Yousef Almehmadi, Joanne E. Nettleship, Khalid Al‐Rumaihi, Bassam Albaba, Daniel Marcus Kelly, Farid Saad · 2020 · The Aging Male
11. Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know
    Ronald Tamler, Tatiana K. Deveney · 2010 · Postgraduate Medicine
12. Pharmacotherapy of Type 2 Diabetes Mellitus: An Update on Drug–Drug Interactions
    Muhammad Amin, Naeti Suksomboon · 2014 · Drug Safety
13. Emerging cardiometabolic complications of androgen deprivation therapy
    Karen Choong, Shehzad Sultan Basaria · 2010 · The Aging Male
14. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)
    Rajib Kumar Bhattacharya, Khera, Gary Blick, Harvey Kushner, Martin M. Miner · 2012 · Clinical Interventions in Aging
15. Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review
    Satesh Kumar, Mahima Khatri, Rahat Ahmed Memon, Jordan Llerena-Velastegui, Kristina Zumbana-Podaneva, Daniela Benitez-Gutierrez, Bilawal Nadeem, Akhil Raj Anumolu, Masood Azhar, Ahmad Zain · 2022 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
16. The Paradox Dividing Testosterone Deficiency Symptoms and Androgen Assays: A Closer Look at the Cellular and Molecular Mechanisms of Androgen Action
    Malcolm E. Carruthers · 2008 · The Journal of Sexual Medicine
17. Testosterone Protects Against Glucotoxicity-Induced Apoptosis of Pancreatic β-Cells (INS-1) and Male Mouse Pancreatic Islets
    Wanthanee Hanchang, Namoiy Semprasert, Thawornchai Limjindaporn, Pa‐thai Yenchitsomanus, Suwattanee Kooptiwut · 2013 · Endocrinology
18. Role of central and peripheral aminopeptidase activities in the control of blood pressure: a working hypothesis
    Manuel R. Ramírez, Isabel Prieto, Francisco Alba, Francisco Vives, Inmaculada Banegas, Marc de Gasparo · 2008 · Heart Failure Reviews
19. Androgen Deficiency in Aging and Metabolically Challenged Men
    Jeremy B. Shelton, Jacob Rajfer · 2011 · Urologic Clinics of North America
20. Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function
    Federica Ermetici, F Donadio, L Iorio, Alexis Elias Malavazos, Alberto Dolci, Erika Peverelli, Anna Maria Barbieri, Lelio F. Morricone, Iacopo Chiodini, Maura Arosio et al. · 2009 · European Journal of Endocrinology
21. Role of Testosterone in the Treatment of Cardiovascular Disease
    Carolyn M. Webb, Peter D. Collins · 2017 · European Cardiology Review
22. Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review
    Wayne J.G. Hellstrom, Darius A. Paduch, Craig F. Donatucci · 2010 · International Urology and Nephrology
23. Male hypogonadism and metabolic syndrome
    Manel Naifar, Nabila Mejdoub Rekik, Meriam Messedi, Khansa Chaabouni, A. Lahiani, Mouna Turki, Mohamed Abid, Fatma Ayedi, K. Jamoussi · 2014 · Andrologia
24. Implications of recent epidemiology studies for the clinical management of lower urinary tract symptoms
    Steven A. Kaplan, Claus G. Roehrborn, Christopher Reginald Chapple, Raymond C. Rosen, Debra E. Irwin, Zoe S. Kopp, Lalitha Padmanabhan Aiyer, Patrick Mollon · 2009 · British Journal of Urology
25. Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care
    Jamie Feldman, Joshua David Safer · 2009 · International Journal of Transgenderism
26. Androgen deficiency and type 2 diabetes mellitus
    Fraser W. Gibb, Mark W. J. Strachan · 2014 · Clinical Biochemistry
27. Androgens and male aging: current evidence of safety and efficacy
    Louis J. Gooren · 2010 · Asian Journal of Andrology
28. Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men
    Matthias Möhlig, Ayman M. Arafat, Martin A. Osterhoff, Frank Isken, Martin O. Weickert, Joachim Spranger, Andreas F. H. Pfeiffer, Christof Schöfl · 2011 · European Journal of Endocrinology
29. Impact of Metabolic Syndrome Factors on Testosterone and SHBG in Type 2 Diabetes Mellitus and Metabolic Syndrome
    Mukhtar Mohammed, Molham Al‐Habori, Ahmed A. Abdullateef, Riyadh Saif-Ali · 2018 · Journal of Diabetes Research
30. Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines
    Rena D. Malik, Brittany R. Lapin, Chihsiung E. Wang, Justin C. Lakeman, Brian T. Helfand · 2014 · The Journal of Sexual Medicine
31. Association between adult weight gain and colorectal cancer: A dose–response meta‐analysis of observational studies
    Qi Chen, Jing Wang, Jinghui Yang, Zhichao Jin, Wentao Shi, Yingyi Qin, Feifei Yu, Jia He · 2014 · International Journal of Cancer
32. Connecting the Lines between Hypogonadism and Atherosclerosis
    Akl C. Fahed, Joanna M. Gholmieh, Sami T. Azar · 2012 · International Journal of Endocrinology
33. Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone
    Hussein F. Sakr, Abdelaziz M. Hussein, Elsayed A. Eid, Mahmoud A. Alkhateeb · 2018 · Steroids
34. Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
    Abdulmaged M. Traish · 2014 · Steroids
35. Testosterone deficiency and cardiovascular mortality
    Abraham Morgentaler · 2014 · Asian Journal of Andrology
36. Growth Hormone and Sex Steroid Effects on Serum Glucose, Insulin, and Lipid Concentrations in Healthy Older Women and Men
    Thomas Münzer, Sherman Mitchell Harman, John David Sorkin, Marc R. Blackman · 2009 · The Journal of Clinical Endocrinology & Metabolism
37. Testosterone reduces AGTR1 expression to prevent β-cell and islet apoptosis from glucotoxicity
    Suwattanee Kooptiwut, Wanthanee Hanchang, Namoiy Semprasert, Mutita Junking, Thawornchai Limjindaporn, Pa‐thai Yenchitsomanus · 2014 · Journal of Endocrinology
38. Testosterone supplementation improves insulin responsiveness in HFD fed male T2DM mice and potentiates insulin signaling in the skeletal muscle and C2C12 myocyte cell line
    Madhuraka Pal, Jasim Khan, Ravi Kumar, Avadhesha Surolia, Sarika Gupta · 2019 · PLoS ONE
39. Testosterone deficiency and the metabolic syndrome
    Bruno Lunenfeld · 2007 · The Aging Male
40. Effects of testosterone replacement on metabolic and inflammatory markers in men with opioid-induced androgen deficiency
    Huang, Grace, Travison, Thomas, Maggio, Marcello, Edwards, Robert R., Basaria, Shehzad · 2016 · Clinical Endocrinology
41. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis
    Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Valeria Carinci, Gianni Casella, Linda Vignozzi, Alessandra Sforza, Mario Maggi · 2024 · Expert Opinion on Drug Safety
42. Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System
    Malik, Rena D., Wang, Chihsiung E., Lapin, Brittany, Lakeman, Justin C., Helfand, Brian T. · 2015 · Urology
43. Dietary supplementation with docosahexaenoic acid rich fish oil increases circulating levels of testosterone in overweight and obese men
    Kylie A. Abbott, Tracy L. Burrows, Shamasunder Acharya, Rohith N. Thota, Manohar L. Garg · 2020 · Prostaglandins Leukotrienes and Essential Fatty Acids
44. Mechanisms in endocrinology: hypogonadism and metabolic health in men—novel insights into pathophysiology
    Clare Miller, Lauren Madden-Doyle, Channa Nalin Jayasena, Marie McIlroy, Mark Sherlock, Michael O’Reilly · 2024 · European Journal of Endocrinology
45. Klinefelter Syndrome and Diabetes
    Mark J. O’Connor, Emma Snyder, Frances J. Hayes · 2019 · Current Diabetes Reports
46. Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study
    Ahmad Rajeh Al-Qudimat, Raed M. Al‐Zoubi, Aksam A Yassin, Mustafa Mohamed Alwani, Omar M. Aboumarzouk, Khalid Al‐Rumaihi, Raidh A. Talib, Abdulla Al Ansari · 2021 · Arab Journal of Urology
47. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data
    Mustafa Mohamed Alwani, Aksam A Yassin, Raidh A. Talib, Ahmad Rajeh Al-Qudimat, Omar M. Aboumarzouk, Raed M. Al‐Zoubi, Farid Saad, Karim Sultan Haider, Abdulla Al Ansari · 2021 · Vascular Health and Risk Management
48. Effects of testosterone treatment on transgender males: A single-institution study
    Sira Korpaisarn, Dararat Chiewchalermsri, Jiraporn Arunakul, Orawee Chinthakanan, Preamrudee Poomthavorn, Chutintorn Sriphrapradang · 2021 · SAGE Open Medicine
49. Testosterone and coronary artery disease in men
    Carolyn M. Webb, Peter D. Collins · 2010 · Maturitas
50. Secondary causes of obesity
    Jocelyne Georges Karam, Samy I. McFarlane · 2007 · Therapy
51. Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents
    Madhusmita Misra, Debra K. Katzman, Jennalee Cord, Stephanie Jeanneret Manning, Diane W. Mickley, David B. Herzog, Karen Klahr Miller, Anne Klibanski · 2008 · American Journal of Clinical Nutrition
52. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study
    Roger D. Stanworth, Shabi Akhtar, Kevin Stephen Channer, T. Hugh Jones · 2013 · European Journal of Endocrinology
53. Relationship between insulin and hypogonadism in men with metabolic syndrome
    Amanda D. A. Caldas, Adriana Lofrano Alves Porto, Lucília Domingues Casulari da Motta, Luíz Augusto Casulari · 2009 · Arquivos Brasileiros de Endocrinologia & Metabologia
54. Aging Men and Lipids
    Genovefa D. Kolovou, Helen I. Bilianou, Apostolia Marvaki, Dimitri P. Mikhailidis · 2010 · American Journal of Men s Health
55. Cardiovascular effect of testosterone replacement therapy in aging male.
    Davide Francomano, Roberto Bruzziches, Marco Natali, Antônio Aversa, Giovanni Spera · 2010 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
56. Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats
    Junjun Wang, Ting Zhai, Yong Chen · 2018 · International Journal of Molecular Sciences
57. Hypogonadism and metabolic syndrome: review and update
    William Travis Berg, Martin M. Miner · 2020 · Current Opinion in Endocrinology Diabetes and Obesity
58. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications
    Bruno Lapauw, Jean‐Marc Kaufman · 2020 · European Journal of Endocrinology
59. Screening for hypogonadism in diabetes 2008/9: Results from the Cheshire Primary Care cohort
    Simon George Anderson, Adrian Hugh Heald, Novie O. M. Younger, Sumudu Bujawansa, Ram Prakash Narayanan, Alan J. McCulloch, Hugh Thomas Jones · 2011 · Primary care diabetes
60. 12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men
    Martin M. Miner, Rajib Kumar Bhattacharya, Gary Blick, Harvey Kushner, Mohit Khera · 2013 · Postgraduate Medicine
61. Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape
    Sylvia Santosa, Michael D. Jensen · 2014 · Hormone Molecular Biology and Clinical Investigation
62. Male Sexual and Reproductive Health—Does the Urologist Have a Role in Addressing Gender Inequality in Life Expectancy?
    Tharu Tharakan, Carlo Bettocchi, Joana Carvalho, Giovanni Corona, Ulla Nordström Joensen, Hugh Thomas Jones, Ateş Kadıoğlu, Juan Ignacio Martínez‐Salamanca, Ege Can Şerefoğlu, Paolo Verze et al. · 2019 · European Urology Focus
63. Hypopituitarism in the elderly
    Marianna Antonopoulou, Rajeev K. Sharma, Amal Farag, Mary Ann Banerji, Jocelyne Georges Karam · 2012 · Maturitas
64. Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?
    Antônio Aversa, Roberto Bruzziches, Davide Francomano, Marco Natali, Andrea Lenzi · 2009 · Therapeutic Advances in Urology
65. Androgen Pattern in Patients With Type 2 Diabetes-associated Erectile Dysfunction: Impact of Metabolic Control
    Ahmed I. El‐Sakka, Hisham M. Sayed, Khaled Abdullah Tayeb · 2009 · Urology
66. Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review
    Jianzhong Zhang, Bin Yang, Wenhui Xiao, Xiao Li, Hongjun Li · 2018 · World Journal of Urology
67. Testosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus
    Madhuraka Pal, Sarika Gupta · 2016 · Nutrition and Diabetes
68. The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism
    Fahrı Bayram, Gülşah Elbüken, Cengiz Korkmaz, Aydoğan Aydoğdu, Züleyha Karaca, Işıl Çakır · 2015 · Hormone and Metabolic Research
69. Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
    Salman Zahoor Bhat, Adrian Sandra Dobs · 2022 · touchREVIEWS in Endocrinology
70. Acute and Short-term Chronic Testosterone Fluctuation Effects on Glucose Homeostasis, Insulin Sensitivity, and Adiponectin: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Christian Høst, Lars Christian Gormsen, DAVID MICHAEL HOUGAARD, Jens Sandahl Christiansen, Steen B. Pedersen, Claus Højbjerg Gravholt · 2014 · The Journal of Clinical Endocrinology & Metabolism
71. Hypogonadism, ADAM, and hormone replacement
    Michael R. Pinsky, Wayne J.G. Hellstrom · 2010 · Therapeutic Advances in Urology
72. Insulin Sensitivity and Testicular Function in a Cohort of Adult Males Suspected of Being Insulin-Resistant
    Patricio H. Contreras, Felipe G. Serrano, A. M. Salgado, Pilar Vigil P · 2018 · Frontiers in Medicine
73. The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
    Omer Faruk Kırlangıç, Didem Yilmaz‐Oral, Ecem Kaya‐Sezginer, Gamze Toktanis, Aybuke Suveyda Tezgelen, Ekrem Sen, Armagan Khanam, Çetin Volkan Öztekin, Serap Gür · 2020 · Sexual Medicine
74. The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population
    Michał Rabijewski, Lucyna Papierska, Wojciech Zgliczyński, Paweł Piątkiewicz · 2013 · BioMed Research International
75. Effects on Lipoprotein Particles of Long-Term Dehydroepiandrosterone in Elderly Men and Women and Testosterone in Elderly Men
    Manivannan Srinivasan, Brian A. Irving, Robert L. Frye, Peter C. O’Brien, Stacy J. Hartman, Joseph P. McConnell, K. Sreekumaran Nair · 2010 · The Journal of Clinical Endocrinology & Metabolism
76. Prevalence of hypogonadism in male Type 2 diabetes mellitus patients with and without coronary artery disease
    S. V. Madhu, M. Aslam, AJ Aiman, Azaz Ahmad Siddiqui, S Dwivedi · 2016 · Indian Journal of Endocrinology and Metabolism
77. Men’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
    Martin M. Miner · 2011 · Urologic Clinics of North America
78. Endurance Training Regulates Expression of Some Angiogenesis-Related Genes in Cardiac Tissue of Experimentally Induced Diabetic Rats
    Mojdeh Khajehlandi, Lotfali Bolboli, Marefat Siahkuhian, Mohammad Rami, Mohammad Reza Tabandeh, Kayvan Khoramipour, Katsuhiko Suzuki · 2021 · Biomolecules
79. Androgens modulate osteocalcin release by human visceral adipose tissue
    Carlo Foresta, Giacomo Strapazzon, Luca De Toni, Lisa Gianesello, Andrea Bruttocao, Alessandro Scarda, Mario Plebani, Andrea Garolla · 2011 · Clinical Endocrinology
80. Testosterone, Endothelial Health, and Erectile Function
    Ângela Castela, Pedro Vendeira, Carla Costa · 2011 · ISRN Endocrinology
81. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
    Jacob Hassan, Jack Barkin · 2016 · PubMed
82. Testosterone Replacement Therapy and Components of the Metabolic Syndrome
    James E. Anaissie, Natalie H. Roberts, Ping Wang, Faysal A. Yafi · 2017 · Sexual Medicine Reviews
83. Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2 DM : a meta‐analysis of randomized controlled trials
    Kun Zhang, M.‐J. Zhao, Qi An, Yuan Jia, Longlong Fu, Jie Xu, Yi‐Qun Gu · 2017 · Andrology
84. Effect of Eurycoma longifolia standardised aqueous root extract–Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study
    Sasikala M. Chinnappan, Annie A. George, Pragya Pandey, Govinda Narke, Yogendra Kumar Choudhary · 2021 · Food & Nutrition Research
85. Testosterone replacement therapy and cardiovascular risk factors modification
    Elie J Chahla, Mireille El Hayek, John Edward Morley · 2011 · The Aging Male
86. Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)
    Mohit Khera, Luiz Otávio Torres, Ethan D. Grober, Abraham Morgentaler, Martin M. Miner, Thomas Hugh Jones, Jesse Nelson Mills, Andrea Salonia · 2025 · Sexual Medicine Reviews
87. Steroid hormones interrelationships in the metabolic syndrome: An introduction to the ponderostat hypothesis
    M. Alemany · 2012 · HORMONES
88. The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
    Michael Zitzmann, Jann Frederik Cremers, Claudia Krallmann, Sabine Kliesch · 2022 · The Aging Male
89. Male Pelvic Health: A Urological Call to Arms
    Steven A. Kaplan · 2006 · The Journal of Urology
90. Metabolic syndrome and the older male population
    Angela D. Mazza, John Edward Morley · 2007 · The Aging Male
91. Plasma testosterone is associated with Framingham risk score
    Brandon Chock, Tzu-Chun Lin, Chin‐Shang Li, Arthur Swislocki · 2012 · The Aging Male
92. Understanding the Role of Sex in Heart Valve and Major Vascular Diseases
    Shirin Masjedi, Zannatul Ferdous · 2015 · Cardiovascular Engineering and Technology
93. Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases
    Svetlana Yur'evna Kalinchenko, Alexandr Zemlyanoy, Louis J. Gooren · 2009 · Cardiovascular Diabetology
94. Opioid use and diabetes: An overview
    Pawan Sharma, Yatan Pal Singh Balhara · 2016 · Journal of Social Health and Diabetes
95. Canadian Society for the Study of the Aging Male: Response to Health Canada's Position Paper on Testosterone Treatment
    Jerald Bain, Gerald B Brock, Irwin W. Kuzmarov, for the International Consulting Group · 2007 · The Journal of Sexual Medicine
96. Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
    Abraham Morgentaler, Sandeep Dhindsa, Adrian Sandra Dobs, Geoff Ian Hackett, Thomas Hugh Jones, Robert Alan Kloner, Martin M. Miner, Michael Zitzmann, Abdulmaged M. Traish · 2024 · Mayo Clinic Proceedings
97. Cardiometabolic indices predict hypogonadism in male patients with type 2 diabetes
    Nicola Caretta, Paolo Facondo, Silvia Mereu, Andrea Delbarba, Martina Crepaldi, Marco Vedovato, Angelo Avogaro, Alberto Ferlin · 2022 · Journal of Endocrinological Investigation
98. Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management
    Shin‐ichi Hisasue · 2015 · International Journal of Urology
99. Sex steroids influence glucose oxidation through modulation of insulin receptor expression and IRS-1 serine phosphorylation in target tissues of adult male rat
    Muthusamy Thiruppathi, Murugesan Palaniappan, Chinnapaiyan Srinivasan, Karundevi Balasubramanian · 2011 · Molecular and Cellular Biochemistry
100. Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem
     Tomasz Buss, Wojciech Leppert · 2014 · Advances in Therapy